Point of Care Testing Conferece
October 22, 2007, New York City
Enter “CONNEXON” at checkout and receive 10% off registration.
Click here to register today.
Growing Living-tissue Heart Valves a Reality in 3-5 Years
Surgeons will soon be able to literally mend a broken heart using live tissue grown from a patient’s very own stem cells, top cardiologists have said.
International Stem Cell Corporation Creates Human Cornea Tissue From its Parthenote Stem Cells
International Stem Cell has announced that data from an independent third party laboratory has confirmed that it has successfully created tissue compatible with a human cornea from embryonic stem cells.
Neural Stem Cell Study Reveals Mechanism That May Play Role In Cancer
scientists have discovered a key mechanism of neuronal migration – one that may also play an important role in other developmental processes and diseases, including cancer.
Making Gene Therapy Safer: Delivering Genes Via Polymers
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
Gene Therapy Promising Against Arthritis
Some of the most successful treatments for rheumatoid arthritis work by blocking an inflammatory factor called tumor necrosis factor or TNF, and now Dutch researchers have shown in animal experiments that the treatment can be delivered by gene transfer.
Bacteria Successful In Cancer Treatment
Bacteria that thrive in oxygen starved environments have been used successfully to target cancer tumours, delivering gene therapy based anti-cancer treatments, according to scientists.
Skin Stem Cells Used to Mend Spines of Rats
A Toronto-led team of researchers has found a way to use stem cells derived from skin to treat spinal cord injuries in rats.
ReNeuron Gives AGM Update on its ReN001 Stem Cell Therapy for Stroke
A pre-clinical study has now reached its end-point, and, subject to completion of data analysis, no significant or unusual adverse safety effects have been observed in either control or treatment groups.
Introgen’s p53 Immunotherapy Drug Candidate to Advance Into Second Phase 2 Clinical Trial in Small Cell Lung Cancer With National Cancer Institute
Introgen Therapeutics, Inc. and Moffitt Cancer Center have announced plans to begin a phase 2 randomized, controlled study of INGN 225, Introgen’s investigational immunotherapy product in patients with metastatic small-cell lung cancer.
Company Makes Bid for Elite Athletes’ Stem Cells
A Melbourne company is consulting elite sports clubs, including teams in the AFL, about athletes storing stem cells and using them to assist recovery from injuries.
Biobank to Boost Cancer Research
Australian cancer researchers will have access to one of the world’s most comprehensive collections of tissue samples with the launch Tuesday of a new biobank, the Victorian government says.
First Case Of Successful Ovarian Tissue Transplantation Between Two, Non-identical Sisters
A woman, whose ovaries had failed due to damage caused by chemotherapy and radiotherapy, has received a successful ovarian transplant from her genetically non-identical sister.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
The Future (R)evolution of Preimplantation Genetic Diagnosis/Human Leukocyte Antigen Testing: Ethical Reflections
There has been increasing support for combining preimplantation genetic diagnosis (PGD) for specific diseases with a test for human leukocyte antigens (HLA) because the generation of HLA-matched umbilical cord blood cells may save the life of a diseased sibling. A proactive ethical analysis is needed and is presented in this article.
Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations
To generate better-defined cell populations, we established a working protocol for sorting heterogeneous hESC-derived neural cell populations by fluorescence-activated cell sorting (FACS).